While the prion-like behavior of proteins such as amyloid-β, tau and α-synuclein has been extensively studied in the context of AD and PD, recent evidence suggests that similar mechanisms are at play in ALS and FTD. The gene discussed is MAPT; the disease is Alzheimer disease.